SAGE Therapeutics (SAGE) Tops Q4 EPS by 24c
SAGE Therapeutics (NASDAQ: SAGE) reported Q4 EPS of ($1.75), $0.24 better than the analyst estimate of ($1.99).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.
SAGE Therapeutics (NASDAQ: SAGE) reported Q4 EPS of ($1.75), $0.24 better than the analyst estimate of ($1.99).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.